Literature DB >> 23277522

The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers.

Anne Kirsten, Henrik Watz, Frauke Pedersen, Olaf Holz, Rachel Smith, Gerard Bruin, Stephan Koehne-Voss, Helgo Magnussen, David A Waltz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23277522     DOI： 10.1183/09031936.00123612

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

Review 1.  Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.

Authors:  Maria Gabriella Matera; Clive Page; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

Review 2.  Novel Biologicals for the Treatment of Allergic Diseases and Asthma.

Authors:  Hern-Tze Tina Tan; Kazunari Sugita; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2016-10       Impact factor: 4.806

3.  Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.

Authors:  Xin Yang; Han-Rong Feng; Zhi-Min Chen; Song-Min Ying
Journal:  Chin Med J (Engl)       Date:  2018-05-05       Impact factor: 2.628

Review 4.  Potential new targets for drug development in severe asthma.

Authors:  Linda Zhu; Christina E Ciaccio; Thomas B Casale
Journal:  World Allergy Organ J       Date:  2018-10-25       Impact factor: 4.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.